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and responsiveness in patients 
sustaining trauma
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Klaus W Wendt1, Erik Heineman2  
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Abstract
Objective: To assess test–retest reliability, construct validity and responsiveness of the Dutch Short 
Musculoskeletal Function Assessment (SMFA-NL) in patients who sustained acute physical trauma.
Design: A longitudinal cohort study.
Setting: A level 1 trauma center in The Netherlands.
Subjects: Patients who required hospital admission after sustaining an acute physical trauma.
Intervention: Patients completed the SMFA-NL at six weeks, eight weeks and six months post-injury.
Main measure: The measures used were The Dutch Short Musculoskeletal Function Assessment. Test–
retest reliability (between six and eight weeks post-injury) using intraclass correlation coefficients, the 
smallest detectable change and Bland and Altman plots. Construct validity (six weeks post-injury) and 
responsiveness (between six weeks and six months post-injury) were evaluated using the hypothesis 
testing method.
Results: A total of 248 patients (mean age: 46.5, SD: 13.4) participated, 145 patients completed the retest 
questionnaires (eight weeks) and 160 patients completed the responsiveness questionnaires (six months). 
The intraclass correlation coefficients indicated good to excellent reliability on all subscales (0.80 to 
0.98). The smallest detectable change was 17.4 for the Upper Extremity Dysfunction subscale, 11.0 for the 
Lower Extremity Dysfunction subscales, 13.9 for the Problems with Daily Activities subscale and 16.5 for the 
Mental and Emotional Problems subscale. At group level, the smallest detectable change ranged from 1.48 
to 1.96. A total of 86% of the construct validity hypotheses and 79% of the responsiveness hypotheses 
were confirmed.
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Conclusion: This study showed that the SMFA-NL has good to excellent reliability, sufficient construct 
validity and is able to detect change in physical function over time.
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Introduction
Patient-reported outcome measures have become 
increasingly important to evaluate functional out-
come after trauma. Numerous patient-reported out-
come measures have been developed for this purpose, 
yet most are disease- or body-region-specific, hence 
not suitable to assess heterogeneous samples such as 
patients who sustained various kinds of injuries. In 
1999, Swiontkowski et al.1 introduced the Short 
Musculoskeletal Function Assessment (SMFA), a 
patient-reported outcome measure that can be used to 
gauge physical functioning in patients with a broad 
range of musculoskeletal conditions. The SMFA was 
designed as an instrument that is not too specific, nor 
overly general and is considered suitable for hetero-
geneous samples such as patients with a broad range 
of traumatic injuries.2,3
The SMFA originally consisted of two indices: 
the Function Index (34 items) and the Bother Index 
(12 items).1 The Function Index was considered to 
be a relatively strict measure of functional limita-
tions, while the Bother Index indicated the “amount” 
of bother due to the functional limitations. The 
SMFA has been cross-culturally adapted in various 
languages, including Dutch (SMFA-NL).4–9
The two indices were originally reported to be 
valid, reliable and responsive,10,11 although recently 
the Function and Bother indices were shown to 
have insufficient structural validity in Dutch trauma 
patients using the SMFA-NL.12 The findings indi-
cated that the two indices are not a valid representa-
tion of the latent construct physical functioning. 
Only a four-subscale configuration consisting of the 
subscales Upper Extremity Dysfunction, Lower 
Extremity Dysfunction, Problems with Daily 
Activities and Mental and Emotional Problems 
demonstrated sufficient structural validity.12
Although the four-subscale structure showed 
sufficient structural validity in a broad range of 
trauma patients, additional clinimetric properties 
(reliability, construct validity and responsiveness) 
have not yet been evaluated. Evaluation of these 
properties is required to justify usage in clinical 
and research settings. The aim of this study was 
therefore to evaluate test–retest reliability, con-
struct validity and responsiveness of the four sub-
scales of the SMFA-NL in patients with a broad 
range of traumatic injuries.
Methods
Study design and recruitment of patients
A longitudinal cohort study design was used. 
Patients were recruited between October 2012 
and March 2016 at University Medical Center 
Groningen, a level-1 trauma center in the 
Netherlands. The methods employed in this study 
have been reviewed by the local Institutional 
Review Board, which waived further need for 
approval (METc2012.104). Patients consented to 
participate in this study. The study was conducted 
in compliance with the principles outlined in the 
Declaration of Helsinki on ethical principles for 
medical research involving human subjects.
The inclusion criterion was patients admitted 
to the hospital due to acute traumatic injuries. 
Exclusion criteria were age between 18 and 65, 
patients who could not read or write Dutch, inju-
ries that resulted in severe neurological deficits, 
pathological fractures and patients with severe 
psychiatric conditions (such as active psychosis, 
bipolar disorders, major depressive episodes).
Patients were asked to complete six question-
naires (described below) at six weeks post-injury 
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and to complete the SMFA-NL for a second time 
after a two-week interval. Patients received the six 
questionnaires again at six months post-injury. 
Standard questionnaires were used. Patients 
received the questionnaires on paper or electroni-
cally and non-responders were reminded once.
Outcome measures
Short Musculoskeletal Function Assessment. The 
SMFA-NL contains 46 items that can be divided 
into four subscales: Upper Extremity Dysfunction, 
Lower Extremity Dysfunction, Problems with Daily 
Activities and Mental and Emotional Problems.9,12 
All items are scored on a 5-point Likert-type scale. 
The items of each of the SMFA-NL subscales can 
be summed up and divided by the maximum score 
to create subscales, each ranging from 0 to 100, 
where 0 represents best possible function.
Health Utilities Index 3. The Health Utilities Index 
3 is a validated 15-item generic health question-
naire that can be used to assess specific Health-
Related Quality of Life and specific health 
domains including Ambulation, Dexterity, Emo-
tion and Pain.13 The Health-Related Quality of 
Life score (Multi Attribute Score) ranges from 0 
to 1, with a score of 1 as best. The standard “past 
one-week” version was used.13 The Health Utili-
ties Index 3 has been recommended and shown 
valid in a wide range of conditions, including 
patients with acute traumatic injuries.13–19 The 
Health Utilities Index 3 is available in several 
languages, including Dutch.13
EuroQoL-5 Dimensions. The EuroQoL-5 Dimen-
sions (EQ-5D) questionnaire is a generic instru-
ment that can be used to assess health status and 
Health-Related Quality of Life.20 The EQ-5D con-
sists of five items scored on a 3-point scale and 
from which a single index score can be calculated. 
The score ranges from 0 (representing death) to 
100 (representing optimal health).21,22 The EQ-5D 
has been recommended and shown valid for assess-
ing health status and Health-Related Quality of 
Life in trauma patients.14,15,17,23–25 It is available in 
over 180 languages, including Dutch.26
Disabilities of Arm, Shoulder and Hand. The Disa-
bilities of Arm, Shoulder and Hand is a body 
region-specific questionnaire that can be used to 
assess upper extremity dysfunction.27 It consists 
of 30 items that are scored on a 5-point Likert-
type scale, from which a total score can be calcu-
lated. The score ranges from 0 to 100, where 0 
represents best possible function. The Disabili-
ties of Arm, Shoulder and Hand has been cross-
culturally adapted in various languages, including 
Dutch, and has been validated in patients with 
upper extremity injuries.17,28–32
Lower Extremity Functional Scale. The Lower 
Extremity Functional Scale is a body region-spe-
cific questionnaire that can be used to assess 
lower extremity function.33 It consists of 20 
items scored on a 5-point Likert-type scale. 
Items are summed to a total score ranging from 0 
to 80. A score of 80 represents the best possible 
function. The Lower Extremity Functional Scale 
has been cross-culturally adapted in Dutch and 
shown to be valid for assessing lower extremity 
function in patients with traumatic injuries of the 
lower extremity.34–38
Numeric Pain Rating Scale. The 11-point Numeric 
Pain Rating Scale is a valid and frequently used 
unidimensional measurement instrument to assess 
pain in adults.39,40 Scores ranged from 0 to 10 in 
discrete numbers, where 0 indicated no pain at all 
and 10 represented the worst imaginable pain.
Global Rating of Effect. Global Rating of Effect 
questions were used to verify whether no clinical 
change had occurred in the test–retest interval. The 
Global Rating of Effect questions were specified 
for all four subscales of the SMFA-NL, with five 
answer options ranging from “much improved” to 
“much deteriorated.”
Procedures
Clinimetric properties were assessed in accordance 
to the COSMIN guidelines.41 Test–retest reliability42 
of the SMFA-NL was evaluated using the six and 
eight weeks post-injury measurements.
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Construct validity42 was assessed with the six 
weeks post-injury data. A total of 50 hypotheses 
were predefined in terms of expected direction and 
expected magnitude of correlations of the 
SMFA-NL with the following patient-reported out-
come measures and clinical parameters (Table 3 
and Supplemental Appendix 1). Outcome meas-
ures used were Health Utilities Index 3; EQ-5D; 
Disabilities of Arm, Shoulder and Hand; Lower 
Extremity Functional Scale; and Numeric Pain 
Rating Scale. Clinical parameters were Injury 
Severity Score, anatomical injury region, surgical 
complications reported within 30 days of the injury 
and hospital length of stay. Injury severity scores 
were obtained from the Dutch Trauma Registry 
and institutional patient registry.43 Surgical compli-
cations were obtained from the institutional com-
plication registry.
Responsiveness42 was assessed using the six 
weeks and six months post-injury data. Hypotheses 
were predefined for the expected correlation 
between changes in scores on the SMFA-NL and 
changes in scores on the Health Utilities Index 3; 
EQ-5D; Disabilities of Arm, Shoulder and Hand; 
Lower Extremity Functional Scale; and Numeric 
Pain Rating Scale questionnaires (Table 4). 
Additional hypotheses were predefined for dis-
criminative capacity between groups of patients 
based on anatomical injury region or whether a sur-
gical complication was reported within six months 
post-injury (Supplemental Appendix 2).
Statistical analysis
To assess clinimetric properties, a sample size of at 
least 50 patients is considered minimal and 100 
patients preferable.44 Anticipating a 40% loss to 
follow-up and 10%–15% of all patients missing 
one or more items in any of the returned question-
naires, we aimed to include at least 200 patients.
Test–retest reliability was evaluated using the 
intraclass correlation coefficient (ICC 2,1) for abso-
lute agreement and was based on a two-way random 
effects model.45 Only patients who scored the Global 
Rating of Effect question of the specific subscale as 
“not changed” were included in the test–retest analy-
sis. Intraclass correlation coefficients ⩾0.70 were 
considered an indication of good reliability and val-
ues ⩾0.90 an indication of excellent reliability.44
Measurement error was evaluated with the 
standard error of measurement for absolute agree-
ment, smallest detectable change and limits of 
agreement in Bland and Altman plots.45 The small-
est detectable change was calculated at the indi-
vidual and group level.46 In the Bland and Altman 
plots, the difference in scores between the test–
retest measurements were plotted against the mean 
score of the test–retest measurements.47 Limits 
of agreement were calculated as mean test–retest 
difference ± 1.96 SDdifference. One-sample t-tests 
were used for all subscales to determine whether 
the difference between the test and retest measure-
ment was different from zero. A significant differ-
ence was considered evidence of systematic bias.47 
Univariable linear regression analyses were used to 
investigate proportional bias: the effect of the mean 
test–retest scores on the test–retest difference 
scores. Regression coefficients that were statisti-
cally different from zero were considered to be an 
indication of proportional bias.47
Construct validity was considered sufficient 
when at least 75% of the predefined hypotheses 
were confirmed.44 The predefined hypotheses were 
tested using Pearson correlation coefficients for 
continuous variables, and mean differences were 
calculated to assess differences between specific 
groups of patients. Confirmation or rejection of the 
hypotheses was based on the magnitude of the cor-
relation coefficient or mean difference, rather than 
P-values.41 A correlation coefficient <0.3 was con-
sidered low, between 0.3 and 0.59 moderate, and 
⩾0.6 high.
The data of the six weeks post-injury measure-
ment was assessed for floor and ceiling effects. 
Floor or ceiling effects occur when patients score 
the absolute maximum or minimum score on a 
measurement instrument. When ⩾15% of the 
measurements were either the minimum or maxi-
mum score, they were regarded as a floor or ceiling 
effect, respectively.48 Patients without upper or 
lower extremity injuries may be expected to report 
the best possible score on the Upper or Lower 
Extremity Dysfunction subscales, respectively. 
Hence, floor and ceiling effects on the Upper and 
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Lower extremity subscales were analyzed in 
patients who had an upper or lower extremity 
injury, respectively. The entire study sample was 
used to analyze floor and ceiling effects for the 
Problems with Daily Activities and Mental and 
Emotional Problems subscales.
A total of 42 predefined hypotheses (Table 4, 
Supplemental Appendix 2) on responsiveness of 
the SMFA-NL were tested using Pearson correla-
tion coefficients. For responsiveness, both meas-
urements may carry measurement error; therefore, 
correlation coefficients <0.25 were considered 
low, between 0.25 and 0.49 moderate and ⩾0.5 
high.49 Responsiveness was considered sufficient 
when at least 75% of the predefined hypotheses 
were confirmed.44
Results
A total of 248 patients completed the questionnaires 
at six weeks post-injury. The response rate was 
64%. The general characteristics of the study sam-
ple are shown in Table 1. Most patients were treated 
surgically and the lower extremity was the most 
common anatomical region of injury (Table 1). 
Several patients did not disclose marital status or 
educational level (Table 1). In total, 145 patients 
completed both the test and retest questionnaire. A 
total of 160 patients completed both the six weeks 
and six months post-injury questionnaires.
Clinimetric properties
The intraclass correlation coefficients of the Upper 
Extremity Dysfunction and Mental and Emotional 
Problems subscales indicated good reliability 
(Table 2). The Lower Extremity Dysfunction and 
Problems with Daily Activities subscales demon-
strated excellent reliability (Table 2). The standard 
error of measurement and smallest detectable 
change are shown in Table 2. Least measurement 
error was demonstrated for the Lower Extremity 
Dysfunction subscale, indicating best precision 
among the four subscales. The Upper Extremity 
Dysfunction Subscale demonstrated most measure-
ment error. Bland and Altman plots do not show an 
upward or downward trend for any of the subscales 
(Figure 1). The measurements were equally spread 
above and below the 0 line for all subscales. The 
limits of agreement were smallest for the Lower 
Extremity Dysfunction and Problems with Daily 
Activities subscales and widest for the Upper 
Extremity Dysfunction subscale. The mean test–
retest differences of the subscales were not signifi-
cantly different from zero for the Upper Extremity 
Table 1. General characteristics of the study sample.
General characteristics N (%)
Gender (n = 248)
 Male 148 (60)
 Female 100 (40)
Age (n = 248) 46.5 (13.4)a
Marital status (n = 218)
 Single 75 (33)
 With partner 144 (67)
Educational level (n = 206)
 Elementary school 3 (1)
 High school 70 (31)
 College 70 (31)
 Bachelor’s degree or higher 81 (36)
 Other 4 (1)
Injuries (n = 678)
 Head and neck 40 (6)
 Face 30 (4)
 Thorax 62 (9)
 Abdomen 25 (4)
 Spine 98 (14)
 Upper extremity 155 (23)
 Lower extremity and pelvic bones 214 (32)
 Skinb/other 54 (8)
Injury Severity Score (n = 248)
 All patients 4 (1–42)c
 Major trauma (ISS ⩾ 16) 35 (14)
Treatment (n = 248)
 Conservative treatment 43 (17)
 Surgeryd 205 (83)
Surgical complication within 30 days 
(n = 248)
36 (15)
ISS: Injury Severity Score.
aPresented as mean (SD).
bSuperficial injuries (abrasion, contusion, lacerations, regard-
less of anatomical region).
cPresented as median (range).
dRequiring surgery for at least one of the injuries.
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Dysfunction, Problems with Daily Activities and 
Mental and Emotional Problems subscales (Table 
2), indicating there was no evidence for systematic 
bias. Systematic bias was observed for the Lower 
Extremity Dysfunction subscale (Table 2). None of 
the regression coefficients were significantly dif-
ferent from zero, indicating there was no evidence 
of proportional bias (Table 2).
The correlation of the SMFA-NL subscales with 
other patient-reported outcome measures and clini-
cal parameters is shown in Table 3. In total, 43 of 
the 50 (86%) pre-specified hypotheses were con-
firmed. All correlation coefficients that were 
expected to be high were confirmed as such. All but 
one of the hypotheses expected to have a low cor-
relation were confirmed. Five out of the six hypoth-
eses on discriminative validity were confirmed 
(Supplemental Appendix 1). Patients who suffered 
a surgical complication within 30 days scored 14.5 
points higher on the Problems with Daily Activities 
subscale (Supplemental Appendix 1). Patients with 
an upper extremity injury scored 20.5 points higher 
on the Upper Extremity Dysfunction subscale than 
patients without an upper extremity injury. Patients 
with a lower extremity injury scored 31.4 points 
higher on the Lower Extremity Dysfunction sub-
scale than those without a lower extremity injury.
A floor effect was observed for the Upper 
Extremity Dysfunction subscale: among patients 
with an upper extremity injury, 23 patients (20%) 
scored the lowest possible score. In this group, 16 
(70%) patients had a fractured clavicle or scapula, 
or had a small injury to the hand. Other subscales 
did not show floor or ceiling effects.
The expected Pearson correlation coefficients of 
changes in scores between the six weeks and six 
months post-injury measurement on the SMFA-NL 
and changes in score on other patient-reported out-
come measures are shown in Table 4 and 
Supplemental Appendix 2. Of the 43 predefined 
hypotheses, 34 (79%) were confirmed. The Upper 
Extremity Dysfunction subscale showed high cor-
relations with the Health Utilities Index 3 Dexterity 
subscale and a low correlation with Health Utilities 
Index 3 Ambulation. The Upper Extremity 
Dysfunction subscale showed a correlation of 0.37 
Table 2. Reliability, measurement error, and systematic bias and proportional bias.
Subscales of the SMFA-NL
 UED LED PDA MEP
Meantest (SD) 8.9 (19.0) 23.9 (26.8) 53.7 (29.2) 19.8 (13.4)
Meanretest (SD) 8.8 (18.9) 22.4 (26.5) 52.0 (28.8) 19.8 (13.1)
Reliability and measurement error
 ICC(2,1)agr 0.89 0.98 0.97 0.80
 (95% CI) (0.84–0.93) (0.96–0.99) (0.95–0.98) (0.69–0.87)
 SEMagr 6.28 3.97 5.03 5.95
 SDCind 17.4 11.0 13.9 16.5
 SDCgr 1.93 1.48 1.95 1.96
Systematic bias
 Mean difference −0.10 −1.55 −1.76 0.00
 P-value 0.9 0.04 0.07 1.0
Proportional bias
 β −0.01 −0.06 −0.56 −0.03
 P-value 0.9 0.7 0.7 0.8
UED: Upper Extremity Dysfunction; LED: Lower Extremity Dysfunction; PDA: Problems with Daily Activities; MEP: Mental and 
Emotional Problems; Test: six weeks post-injury; retest: eight weeks post-injury; ICC(2,1)agr: intraclass correlation coefficient for 
agreement using a two-way random effects model; SEMagr: standard error of measurement for agreement; SDCind: smallest detect-
able change at the individual level; SDCgr: smallest detectable change at the group level; β: standardized regression coefficient; 
SMFA-NL: Short Musculoskeletal Function Assessment.
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with the Disabilities of Arm, Shoulder and Hand. 
The Lower Extremity Dysfunction subscale showed 
high correlations with the EQ-5D; Health Utilities 
Index 3 Ambulation subscale; Disabilities of Arm, 
Shoulder and Hand; and Lower Extremity 
Functional Scale. The Problems with Daily 
Activities and Upper and Lower Extremity 
Dysfunction subscales showed a low correlation 
with Health Utilities Index 3 Emotion. The change 
in Problems with Daily Activities score showed 
high correlations with the EQ-5D; Health Utilities 
Index 3 Multi Attribute Score; Health Utilities 
Index 3 Ambulation; Disabilities of Arm, Shoulder 
and Hand; and Lower Extremity Functional Scale. 
Hypotheses on the Mental and Emotional Problems 
subscale were confirmed least. Raw scores and 
change in scores of the six weeks to six months 
interval are shown in Table 5.
Discussion
This study demonstrated that the SMFA-NL has 
good to excellent test–retest reliability, sufficient 
construct validity and responsiveness to assess phys-
ical function in patients who sustained trauma. Due 
to floor effects, the clinical usability of the Upper 
Extremity Dysfunction subscale may be limited.
To justify the use of the SMFA-NL in clinical 
practice or in applied research, it is important to estab-
lish its clinimetric measurement properties in con-
cordance with the COSMIN criteria.41 The reliability 
and validity of the SMFA-NL enable assessment of 

































































































E: expected direction and magnitude of predefined correlations of the SMFA-NL subscales with other instruments and param-
eters; high: r ⩾ 0.6; moderate: 0.3 ⩽ r < 0.6; low: r < 0.3; (+) or (–): expected direction of correlation; O: observed correlation; 
HUI3: Health Utilities Index Mark 3; DASH: Disabilities of the Arm Shoulder and Hand; LEFS: Lower Extremity Functional Scale; 
ISS: Injury Severity Score; SMFA-NL: Short Musculoskeletal Function Assessment.
Expected low correlations not assigned a direction since it was hypothesized that the correlation coefficient would be close to 
zero. Confirmed hypotheses are shown in bold.
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physical function at a single point in time. The respon-
siveness of the SMFA-NL allows evaluation of 
(recovery of) physical function over time. The 
SMFA-NL can be applied in patients with a broad 
range of injuries, ranging from wounds to major 
trauma.
Previous studies have assessed the clinimetric 
properties of the SMFA-NL in trauma patients, 
using a slightly modified version where double-
barreled items were split.50,51 Van Son et al.51 
assessed the clinimetric properties in patients with 
isolated unilateral lower extremity fractures and 
upper extremity fractures. They reported sufficient 
reliability, construct validity and responsiveness, 
yet in that study two different three-subscale struc-
tures were used to calculate scores: one set of sub-
scales for patients with upper extremity fractures 
and another set of subscales for patients with lower 
extremity fractures. This complicates the scoring, 
especially in patients who suffered fractures of 
both the upper and lower extremities. Van Delft-
Schreurs et al.50 assessed the clinimetric properties 
in a sample that only contained major trauma 
patients, one to four years post-injury. In that study, 
another unique set of three subscales were used, 
which were concluded to be valid. However, in that 
study, test–retest reliability was not evaluated and 
responsiveness was not evaluated as a longitudinal 
measurement, but was calculated as the difference 
with a pre-injury baseline-group. In this study, the 
clinimetric measurement properties of the 
SMFA-NL have been investigated more exten-
sively and in a broader range of trauma patients. 
Furthermore, the four-subscale configuration of the 

















































































E: expected direction and magnitude of predefined correlations of the SMFA-NL subscales with other instruments and param-
eters; high: r ⩾ 0.5; moderate: 0.25 ⩽ r < 0.5; low: r < 0.25; (+) or (–): expected direction of correlation; HUI3: Health Utilities 
Index Mark 3; DASH: Disabilities of the Arm Shoulder and Hand; LEFS: Lower Extremity Functional Scale; ISS: Injury Severity 
Score; SMFA-NL: Short Musculoskeletal Function Assessment; O: observed correlation; EQ-5D: EuroQoL-5 Dimensions.
Expected low correlations were not assigned a direction since it was hypothesized that the correlation coefficient would be close 
to zero. Confirmed hypotheses are shown in bold.
Hypotheses were formulated as follows: The correlation of change in … score with change in … score is expected to be …. 
For example, the correlation of change in EQ-5D index score with change in SMFA-NL Problems with Daily Activities score is 
expected to be high.
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SMFA-NL may be easily applied in day-to-day 
clinical practice, as there is just one set of subscales 
for all trauma patients.
The choice of the instruments used for the 
assessment of construct validity responsiveness 
was based on the constructs that are evaluated with 
the subscales of the SMFA-NL. The Disabilities of 
the Arm Shoulder and Hand (DASH) and Lower 
Extremity Functional Scale (LEFS) are extremity-
specific questionnaires that match the extremity-
specific subscales of the SMFA-NL. The Health 
Utilities Index 3 and the EQ-5D are complemen-
tary generic instruments that aim to cover the entire 
spectrum of disease and functional limitations, 
including constructs such as daily activities and 
mental and emotional problems. In a guideline 
aimed at assessing health status after trauma, it has 
been advised to use both the Health Utilities Index 
3 and EQ-5D.14
The floor effect observed for the Upper Extremity 
Dysfunction subscale was mainly caused by patients 
with a relatively mild injury of the upper extremity. 
Figure 1. Bland and Altman plots of the test–retest analysis. Bland and Altman plots of the test–retest analysis for 
all SMFA-NL subscales: Upper Extremity Dysfunction (UED), Lower Extremity Dysfunction (LED), Problems with 
Daily Activities (PDA) and Mental and Emotional Problems (MEP). Blue line: mean test–retest difference; red dashed 
lines: limits of agreement. LoA: limit of agreement.
932 Clinical Rehabilitation 33(5)
This may indicate that the subscale lacks sensitivity 
to detect some upper extremity functional problems. 
Alternatively, these patients may have already 
recovered after six weeks. Floor effects pose largest 
problems in longitudinal analyses, as patients cannot 
show any further improvement in score even if they 
do experience clinical improvement.49 Therefore, 
the use of the Upper Extremity Dysfunction subscale 
may be limited, especially in patients with a rela-
tively mild injury of the upper extremity. Similar to 
the findings in this study, floor effects have been 
reported in the development study of the SMFA and 
in studies of the SMFA that evaluated clinimetric 
properties of an upper extremity subscale.1,9,50,51 The 
addition of items with a higher difficulty may 
resolve significant floor effects, yet modification of 
the SMFA-NL was beyond the scope of this study.
The systematic bias of the Lower Extremity 
Dysfunction subscale was considered small and may 
have been caused by subclinical recovery of the 
lower extremity. Systematic bias of the SMFA had 
only been investigated in one study. Reininga et al.9 
reported a small but irrelevant systematic bias for the 
Bother Index of 2 points. We considered the system-
atic bias to have had a small influence on the reliabil-
ity of the Lower Extremity Dysfunction Subscale, as 
the bias was smaller than the measurement error and 
may be easily controlled for when needed.52
The smallest detectable change is an important 
benchmark to interpret changes in scores. It indi-
cates the point from which a change can be consid-
ered a true change and not due to measurement 
error.44,53 The smallest detectable change values of 
the SMFA-NL at group level were considered 
small. However, at the individual level, the small-
est detectable change values of the Upper Extremity 
Dysfunction and Mental and Emotional Problems 
subscales may limit the ability to assess early clini-
cal changes.
Two studies have reported smallest detectable 
change values of the SMFA.9,54 Pinsker et al. 
reported a smallest detectable change of 9.6 points 
on the function index. This is a much lower smallest 
detectable change value compared to our findings; 
however, that was in patients with clinically stable 
end-stage ankle arthritis, which is not representative 
of the sample of this study.54 In a sample of Dutch 
patients with various musculoskeletal disorders, 
Reininga et al.9 reported standard error of measure-
ment values from which smallest detectable change 
values could be calculated. Despite a slightly higher 
reliability (intraclass correlation coefficients range: 
0.91–0.96) than in this study, the smallest detectable 
changes of Reininga et al.9 were larger than in this 
study (range: 23.3–31.3 points). Reininga et al.9 
studied a more heterogeneous sample, which may 
have led to higher reliability statistics, while not 
affecting absolute measurement error. In addition, 
no external criterion was applied to identify patients 
who had not changed, which may have increased 
measurement error. Although the measurement error 
in this study (expressed as smallest detectable 
change) was smaller than in the study by Reininga 
et al., the interpretation of a change in score requires 
an additional benchmark: the minimal important 
change.53 The minimal important change reflects 
which change in score is a meaningful change to 
patients. However, a minimal important change is 
currently not known for the SMFA.3
The two-week test–retest interval may be con-
sidered a limitation of this study, as it carries the 
risk of recall bias. However, a two-week test–retest 
interval is generally considered a safe margin to 
avoid significant recall bias, but short enough to 
Table 5. SMFA-NL scores of the six weeks to six months interval.
Mean6w (SD) Mean6m (SD) Mean diff (SD)
Upper Extremity Dysfunction (n = 159) 13.2 (20.4) 6.2 (11.8) 7.0 (13.8)
Lower Extremity Dysfunction (n = 151) 32.3 (24.7) 17.0 (17.7) 15.3 (19.2)
Problems with Daily Activities (n = 152) 53.1 (24.3) 27.9 (21.1) 25.1 (20.9)
Mental and Emotional Problems (n = 160) 24.2 (14.4) 20.1 (14.3) 4.1 (12.5)
Mean6w: mean of the six weeks post-injury measurement; Mean6m: mean of the six months post-injury measurement; mean diff: 
mean difference of the six weeks and six months post-injury measurements; SMFA-NL: Short Musculoskeletal Function Assessment.
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avoid clinical improvement.44 Additional Global 
Rating of Effect questions were used to exclude 
that patients experienced clinical change, although 
these questions may not capture subclinical change. 
Second, although the sample size was considered 
adequate, due to the longitudinal study design 
some patients were lost to follow-up for the eight 
weeks and six months measurements. This may 
have induced selection bias. Third, the clinical usa-
bility of the Upper Extremity Dysfunction subscale 
may be limited, especially in patients with a rela-
tively mild injury of the upper extremity.
One of the strengths of this study was that this 
was the first study in which the responsiveness of 
the SMFA has been evaluated using the COSMIN 
guidelines, in which hypotheses-testing is recom-
mended.41 Other studies have reported standard-
ized response means, which is an effect size-based 
measure that does not relate to the validity of the 
measured change.1,4,5,50,51
The SMFA-NL may be used in clinical practice as 
an overall evaluation of physical function at one 
moment, or as an instrument to assess change in 
physical function over time. In research the 
SMFA-NL may be used whenever the researcher is 
interested in the functional status or functional recov-
ery of an injured patient, for example t in clinical tri-
als in which conservative and surgical treatment of 
fractures are compared. To improve interpretability 
of the SMFA-NL, future research may be dedicated 
to assess which change in score is important to a 
patient and which difference in score between groups 
of patients may be considered relevant.
Clinical messages
•• The Short Musculoskeletal Function 
Assessment may be used to assess physi-
cal functioning at a single moment in 
patients who sustained trauma.
•• The Short Musculoskeletal Function 
Assessment may be used to measure 
change in physical function over time in 
patients who sustained trauma.
•• Floor and ceiling effects may limit the use-
fulness of the Upper Extremity Dysfunction 
subscale in longitudinal analyses.
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